{
    "title": "Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12608755/Bristol-Myers-Squibb-acquire-Mirati-4-8-billion-deal.html",
    "date": "2023-10-08",
    "keywords": [
        "cancer",
        "bristol",
        "company",
        "share",
        "cash",
        "mirati",
        "oncology",
        "drug",
        "decade",
        "portfolio",
        "lung",
        "transaction",
        "statement",
        "half",
        "lenkowsky",
        "officer",
        "value",
        "boerner",
        "blood",
        "erman",
        "sunday",
        "drugmaker",
        "business",
        "revenue",
        "patent",
        "miratis",
        "compound",
        "mrtx1719",
        "interview",
        "standpoint",
        "commercialization",
        "hand",
        "enterprise",
        "valuewe",
        "deal",
        "contingent",
        "opportunity",
        "combination",
        "debt",
        "food",
        "administration",
        "step",
        "strengthen",
        "pipeline",
        "ceo",
        "chief",
        "demand",
        "treatment",
        "revlimid",
        "thinner",
        "face",
        "competition",
        "time",
        "high",
        "apiece",
        "giovanni",
        "caforio",
        "november",
        "year",
        "developer",
        "point",
        "arsenal",
        "ahire",
        "gulwani",
        "editing",
        "shumaker",
        "diane",
        "craft",
        "andrea",
        "ricci",
        "michael",
        "perry"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}